Analgesics drive growth at J&J's OTC business

19 April 2016 - Deborah Wilkes

Archived

Johnson & Johnson's US OTC sales increased by 13.8% in the first quarter of 2016, as sales of OTC analgesics rose by almost a fifth.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: